Ocular Therapeutix Inc (OCUL)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 12,721,460 $115,765,286 +38% 3.31%
2.
VenBio Select Advisor

Kurt Von Emster

7,148,936 $65,055,318 0.75%
3.
Opaleye Management

James A. Silverman

6,653,138 $60,543,556 +10% 13.19%
4.
Logos Capital

Arsani William

5,811,436 $51,991,614 +46% 4.2%
5. 5,420,601 $48,419,890 +54% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.52 930,851 8,591,401 2024-02-26 Filing
$3.25 1,538,461 7,660,550 2023-12-14 Filing
$3.81 6,500 Officer, Director 6,500 2023-08-30 Filing
$3.50 7,328 Large Shareholder 6,122,089 2022-11-07 Filing
$3.90 10,000 Large Shareholder 6,114,761 2022-10-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.84 2,274 Officer 178,026 2024-05-23 Filing
$5.79 21,626 Officer, Director 833,353 2024-05-23 Filing
$4.86 5,910 Officer 123,689 2024-02-05 Filing
$4.86 6,029 Officer 161,493 2024-02-05 Filing
$4.86 6,346 Officer 153,054 2024-02-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 7,775,760 $34,679,890 2.37%
2. 5,761,533 $25,696,437 0%
3. 5,118,102 $22,826,735 0%
4. 4,500,159 $20,070,709 0%
5. 2,443,607 $10,898,487 2.45%
News See All